Giuliano Rizzardini

InstitutionUniversity of the Witwatersrand
AddressJohannesburg
South Africa
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 4 publications in May 2020
    All Publications
    Bar chart showing 151 publications over 20 distinct years, with a maximum of 16 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Capetti AF, Stangalini CA, Borgonovo F, Mileto D, Oreni L, Dedivitiis G, Lupo A, Cossu MV, Bilardo L, Giacomelli A, Galli M, Rizzardini G. Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine. Clin Infect Dis. 2021 09 15; 73(6):e1402-e1403. PMID: 33693610.
      Citations: 3     Fields:    Translation:Humans
    2. Capetti AF, Borgonovo F, Mileto D, Gagliardi G, Mariani C, Lupo A, Dedivitiis G, Meraviglia P, Pellicciotta M, Armiento L, Cossu MV, Rizzardini G. One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG. J Infect. 2021 08; 83(2):237-279. PMID: 34052240.
      Citations: 1     Fields:    Translation:Humans
    3. Ferretti F, Cannatelli R, Benucci M, Carmagnola S, Clementi E, Danelli P, Dilillo D, Fiorina P, Galli M, Gallieni M, Genovese G, Giorgi V, Invernizzi A, Maconi G, Maier JA, Marzano AV, Morpurgo PS, Nebuloni M, Radovanovic D, Riva A, Rizzardini G, Sabiu G, Santus P, Staurenghi G, Zuccotti G, Sarzi-Puttini PC, Ardizzone S. How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group. Front Immunol. 2021; 12:656362. PMID: 33936084.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    4. Maconi G, Bosetti C, De Monti A, Boyapati RK, Shelton E, Piazza N, Carvalhas Gabrielli AM, Lenti MV, Bezzio C, Ricci C, Greco S, Romeo S, Giangregorio F, Gridavilla D, Tagliani F, Massari A, Pastorelli L, Di Sabatino A, Saibeni S, Alicante S, Ferretti F, Rizzardini G, Galli M, Ardizzone S. Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population. Dig Liver Dis. 2021 03; 53(3):263-270. PMID: 33483259.
      Citations: 6     Fields:    Translation:Humans
    5. Giacomelli A, Ridolfo AL, Oreni L, Vimercati S, Albrecht M, Cattaneo D, Rimoldi SG, Rizzardini G, Galli M, Antinori S. Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? Pharmacol Res. 2021 02; 164:105403. PMID: 33359914.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Vespro V, Andrisani MC, Fusco S, Di Meglio L, Plensich G, Scarabelli A, Stellato E, Ierardi AM, Scudeller L, Coppola A, Gori A, Pesenti A, Grasselli G, Aliberti S, Blasi F, Villa C, Ippolito S, Pirrò B, Damiani G, Galli M, Rizzardini G, Catena E, Orlandi MA, Magnani S, Cipolla G, Ianniello AA, Petrillo M, Xhepa G, Scamporrino A, Cazzulani A, Carrafiello G. Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy. Intern Emerg Med. 2021 08; 16(5):1173-1181. PMID: 33216258.
      Citations: 3     Fields:    Translation:Humans
    7. Mileto D, Foschi A, Mancon A, Merli S, Staurenghi F, Pezzati L, Rizzo A, Conti F, Romeri F, Bernacchia D, Meroni R, Rizzardini G, Gismondo MR, Micheli V. A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? Int J Infect Dis. 2021 Mar; 104:631-633. PMID: 33227514.
      Citations: 3     Fields:    Translation:Humans
    8. Giacomelli A, Pagani G, Ridolfo AL, Oreni L, Conti F, Pezzati L, Bradanini L, Casalini G, Bassoli C, Morena V, Passerini S, Rizzardini G, Cogliati C, Ceriani E, Colombo R, Rusconi S, Gervasoni C, Cattaneo D, Antinori S, Galli M. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. J Med Virol. 2021 03; 93(3):1421-1427. PMID: 32776534.
      Citations: 5     Fields:    Translation:Humans
    9. Capetti AF, Borgonovo F, Morena V, Lupo A, Cossu MV, Passerini M, Dedivitiis G, Rizzardini G. Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers. J Med Virol. 2021 03; 93(3):1766-1769. PMID: 32881014.
      Citations: 2     Fields:    Translation:Humans
    10. Invernizzi A, Torre A, Parrulli S, Zicarelli F, Schiuma M, Colombo V, Giacomelli A, Cigada M, Milazzo L, Ridolfo A, Faggion I, Cordier L, Oldani M, Marini S, Villa P, Rizzardini G, Galli M, Antinori S, Staurenghi G, Meroni L. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020 Oct; 27:100550. PMID: 32984785.
      Citations: 46     
    11. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 07 28; 71(15):889-890. PMID: 32215618.
      Citations: 441     Fields:    Translation:HumansCellsPHPublic Health
    12. Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, Bonazzetti C, Covizzi A, Schiuma M, Passerini M, Piscaglia M, Coen M, Gubertini G, Rizzardini G, Cogliati C, Brambilla AM, Colombo R, Castelli A, Rech R, Riva A, Torre A, Meroni L, Rusconi S, Antinori S, Galli M. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study. Pharmacol Res. 2020 08; 158:104931. PMID: 32446978.
      Citations: 87     Fields:    Translation:HumansCellsPHPublic Health
    13. Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C, Torre A, Cossu MV, Minari C, Ballone E, Perotti A, Mileto D, Niero F, Merli S, Foschi A, Vimercati S, Rizzardini G, Sollima S, Bradanini L, Galimberti L, Colombo R, Micheli V, Negri C, Ridolfo AL, Meroni L, Galli M, Antinori S, Corbellino M. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42. PMID: 32448770.
      Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
    14. Antinori S, Cossu MV, Ridolfo AL, Rech R, Bonazzetti C, Pagani G, Gubertini G, Coen M, Magni C, Castelli A, Borghi B, Colombo R, Giorgi R, Angeli E, Mileto D, Milazzo L, Vimercati S, Pellicciotta M, Corbellino M, Torre A, Rusconi S, Oreni L, Gismondo MR, Giacomelli A, Meroni L, Rizzardini G, Galli M. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacol Res. 2020 08; 158:104899. PMID: 32407959.
      Citations: 59     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    15. Sarzi-Puttini P, Marotto D, Antivalle M, Salaffi F, Atzeni F, Maconi G, Monteleone G, Rizzardini G, Antinori S, Galli M, Ardizzone S. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion. Autoimmun Rev. 2020 07; 19(7):102574. PMID: 32376399.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    16. Zehender G, Lai A, Bergna A, Meroni L, Riva A, Balotta C, Tarkowski M, Gabrieli A, Bernacchia D, Rusconi S, Rizzardini G, Antinori S, Galli M. Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. J Med Virol. 2020 Sep; 92(9):1637-1640. PMID: 32222993.
      Citations: 54     Fields:    Translation:Humans
    17. Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):337-342. PMID: 32202240.
      Citations: 168     Fields:    Translation:HumansCellsPHPublic Health
    Rizzardini's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (239)
    Explore
    _
    Co-Authors (204)
    Explore
    _
    Similar People (60)
    Explore
    _